17-beta-estradiol
Turner Syndrome
Universiti Kebangsaan Malaysia Medical CentrePhase 4 / ApprovedActive
BBB
76/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 64/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Turner Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Genotropin Massachusetts General Hospital | Phase 3 | BB |
Medroxyprogesterone acetate Eli Lilly and Company | Phase 3 | BB |
ORSYTHIA COMPONENT ETHINYL ESTRADIOL Eli Lilly and Company | Phase 3 | BB |
Same molecule, other indications
17-beta-estradiol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →